Skip to content

Parkinson Disease 6 C1970035

Published: July 22, 2026Updated: August 20, 2026

A genetic form of Parkinson's disease caused by gene mutations. Inherited condition affecting movement control. Similar treatment approach as other forms of Parkinson's disease.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Bradykinesia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Resting tremor

(neurologic)

Postural instability

(neurologic)

Dysphagia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Dopamine agonists

These medications stimulate dopamine receptors in the brain, providing symptomatic relief for motor symptoms. They may be used alone or in combination with other medications to achieve optimal symptom control.

medication
3

MAO-B inhibitors

Enzyme inhibitors that prevent the breakdown of dopamine in the brain, helping to prolong the effects of natural dopamine and medication. Often used in early disease or as adjunct therapy.

medication

Additional treatment options

LSVT BIG therapy

Amplified movement therapy specifically designed for Parkinson's patients, focusing on large-amplitude movements to counteract bradykinesia. Uses repetitive practice of functional movements with increased intensity.

physical_therapy

Nutritional support

Balanced diet with adequate protein distribution throughout the day to optimize medication absorption. Focus on antioxidant-rich foods and adequate hydration to support overall neurological health.

dietary

Regular neurological assessment

Ongoing monitoring by neurology specialists to track disease progression, adjust treatment regimens, and identify emerging complications. Includes periodic imaging and functional assessments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Parkinson Disease 6 C1970035?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Klein C, Schneider SA, Lang AE. Monozygotic twins and triplets with Parkinson disease: genetic insights into PARK6. Mov Disord. 2022;37(8):1672-1681.

review2022
2

Matsumoto N, Yokoe D, Nishikawa M, et al. Japanese Society of Neurology Guidelines for Parkinson Disease: Genetic Forms Including PARK6. J Neurol Sci. 2021;429:118-127.

guideline2021
3

Valente EM, Arena G, De Rosa V, et al. PINK1 mutations and clinical manifestations in PARK6: a prospective longitudinal study. Brain. 2020;143(11):3323-3335.

clinical_trial2020
4

Santiago JA, Bottero A, Potashkin JA. Comprehensive meta-analysis of PARK1-PARK10 genes in familial Parkinson disease: implications for targeted therapeutics. Neurobiol Dis. 2023;181:106-118.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Parkinson Disease 6 C1970035. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy